Updates to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV

The Panelon Antiretroviral Guidelines for Adults and Adolescents (the Panel) updated the following section of theGuidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Highlights from the section are summarized below:

DrugDrug Interactions Tables

• The Panel updated the DrugDrug Interactions tables (Tables 24af) with guidance on the interaction potentials between antiretroviral drugs and antiviral drugs (brincidofovir, cidofovir, or tecovirimat) that are currently being used to treat monkeypox.

For a complete list of updates, please seeWhat's New in the Guidelines. To view or download the guidelines, please see the Adult and Adolescent ARV Guidelines section of Clinical Infos website. The guidelines tables and recommendations can also be downloaded as separate PDF files.

Clinical Infowelcomes your feedbackon the latest revisions to theGuidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Please send your comments with the subject line Adult and Adolescent ARV Guidelines to HIVinfo@NIH.gov by September 22, 2022.